Legal & General Group
XFOR icon

Legal & General Group’s X4 Pharmaceuticals XFOR Stock Holding History

Legal & General Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.7K Buy
+7,858
New +$32.2K ﹤0.01% 2881
2025
Q2 		– Sell
-620
Closed -$4.4K – 3556
2025
Q1 		$4.4K Hold
620
– – ﹤0.01% 3296
2024
Q4 		$13.7K Hold
620
– – ﹤0.01% 3169
2024
Q3 		$12.5K Hold
620
– – ﹤0.01% 3226
2024
Q2 		$10.8K Buy
620
+242
+64% +$7.92K ﹤0.01% 3284
2024
Q1 		$15.7K Hold
378
– – ﹤0.01% 3062
2023
Q4 		$9.5K Hold
378
– – ﹤0.01% 3246
2023
Q3 		$12.3K Sell
378
-69
-15% -$3.01K ﹤0.01% 3224
2023
Q2 		$26K Buy
+447
New +$23K ﹤0.01% 3002
2021
Q2 		– Sell
-47
Closed -$12K – 3665
2021
Q1 		$12K Hold
47
– – ﹤0.01% 3331
2020
Q4 		$9K Hold
47
– – ﹤0.01% 3376
2020
Q3 		$10K Sell
47
-15
-24% -$3.6K ﹤0.01% 3240
2020
Q2 		$17K Sell
62
-17
-22% -$4.66K ﹤0.01% 3141
2020
Q1 		$21K Sell
79
-4
-5% -$1.14K ﹤0.01% 2897
2019
Q4 		$27K Buy
83
+17
+26% +$6.1K ﹤0.01% 3097
2019
Q3 		$25K Buy
66
+27
+69% +$10.7K ﹤0.01% 3060
2019
Q2 		$17K Buy
39
+35
+875% +$17.8K ﹤0.01% 3261
2019
Q1 		$2K Hold
4
– – ﹤0.01% 3336
2018
Q4 		$2K Hold
4
– – ﹤0.01% 3372
2018
Q3 		$1K Hold
4
– – ﹤0.01% 3385
2018
Q2 		$3K Hold
4
– – ﹤0.01% 3341
2018
Q1 		$18K Buy
+4
New +$11.6K ﹤0.01% 3132

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's XFOR Position: Q2 2026 in Review

Legal & General Group opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 7,858 shares worth $36.7K. The stake represents ﹤0.01% of the portfolio and ranks #2881 among its holdings. This is a return to the name: Legal & General Group previously reported a position in XFOR as recently as Q1 2025.

Legal & General Group first reported a position in XFOR in Q1 2018 and has held it in 22 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Legal & General Group held 7,858 shares of X4 Pharmaceuticals worth $36.7K as of Q2 2026.
  • X4 Pharmaceuticals was a new Legal & General Group position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2881 holding.
  • Legal & General Group first reported a position in X4 Pharmaceuticals in Q1 2018 and has held it in 22 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.